Mr Bamidele Omotara, university of new haven, United States
Bamidele Omotara is an experienced chemist with a strong background in computational and analytical chemistry. He earned a Master of Science in Chemistry from the University of New Haven (2022-2023) and a Bachelor of Science in Chemistry from Ekiti State University, Nigeria (2010-2016) 🎓. Currently, he volunteers as a Computational Chemist at Bytewave Technologies, using molecular simulations for drug design and reaction modeling 🔬💊. He previously worked as a Quality Control Analyst at Peace Standard Pharmaceutical Industries (2019-2021), performing quality testing and analysis of pharmaceutical products, including injectable emulsions and stability studies ⚗️💉.
Publication profile
Scopus
Education
With a solid academic foundation in chemistry, I obtained my Master of Science from the University of New Haven, West Haven, CT, between January 2022 and December 2023 🧪🎓. This advanced degree built upon the knowledge and skills I acquired during my Bachelor of Science in Chemistry from Ekiti State University, Ado Ekiti, Nigeria, where I studied from January 2010 to January 2016 🧑🔬📚. These educational experiences have equipped me with a strong understanding of chemical principles, laboratory techniques, and research methodologies, preparing me for future endeavors in the field of chemistry 🌍🔬.
Experience
As a Computational Chemist at Bytewave Technologies Inc. (since May 2024), He employ simulations to identify protein-binding sites for new drug molecules and model synthesis reactions, exploring fundamental processes like superconductivity and energy storage. My expertise includes virtual screening, molecular docking, and dynamics for computational drug design 🧪🔬. Previously, I worked as a Quality Control Analyst at Peace Standard Pharmaceutical Industries (April 2019 – December 2021), where he performed quality testing, analyzed raw materials, and ensured batch execution for sterile injectables 💊. My work adhered to global pharmacopeial standards (USP-NF, EP, BP, JP), ensuring top-tier quality control 📈.
Research focus
A.U. Egbemhenghe’s research focuses on computational drug design and the identification of novel small molecules for cancer therapy. 🧬✨ Using techniques like virtual screening, molecular docking, and molecular dynamics simulations, their work targets key cancer-related proteins, such as p53-MDMX interaction and STK17B, to identify effective inhibitors for potential therapeutic use. 💊🔬 Egbemhenghe integrates bioinformatics and molecular modeling to enhance the precision of immuno-oncology compounds, like VISTA-inhibitors, aiming to develop novel treatments that improve cancer outcomes. 🌿🛡️ Their research lies at the intersection of computational biology and oncology drug development. 🖥️🧑⚕️
Publication top notes
Conclusion
His innovative research in computational chemistry, particularly in drug design and cancer therapy, combined with his practical industry experience, Mr. Omotara has made significant strides in his field, making him an excellent candidate for the Excellence in Research Award.